Trading Volumes in September Down Year-over-Year; Rebound From August
2012 Levels
NEW YORK--(BUSINESS WIRE)--Oct. 10, 2012--
NYSE Euronext (NYX) today announced trading volumes for its global
derivatives and cash equities exchanges for September 20121.
Trading volumes in September 2012 were down year-over-year, but
rebounded across the four principal trading venues from lower levels
recorded in August 2012.
Highlights
-
NYSE Euronext global derivatives ADV in September 2012 of 7.7 million
contracts decreased 19.4% compared to September 2011, but increased
19.8% from August 2012 levels.
-
NYSE Euronext European derivatives products ADV in September 2012 of
3.5 million contracts decreased 28.2% compared to September 2011, but
increased 6.5% from August 2012. Excluding Bclear, NYSE Liffe's trade
administration and clearing service for OTC products, European
derivatives products ADV decreased 20.9% compared to September 2011,
but increased 30.6% from August 2012 levels.
-
NYSE Euronext U.S. equity options ADV of 4.1 million contracts in
September 2012 decreased 10.2% compared to September 2011 levels, but
increased 33.5% from August 2012. NYSE Euronext’s U.S. options
exchanges accounted for 26.0% of total U.S. consolidated equity
options trading in September 2012, down from 26.8% in September 2011,
but up from 24.8% in August 2012.
-
NYSE Liffe U.S. ADV of approximately 83,700 contracts decreased 26.2%
compared to September 2011, but increased 32.4% versus August 2012.
-
NYSE Euronext European cash products ADV of 1.4 million transactions
in September 2012 decreased 24.2% compared to September 2011, but
increased 31.3% from August 2012 levels.
-
NYSE Euronext U.S. cash products handled ADV of 1.7 billion shares in
September 2012 decreased 34.7% compared to September 2011, but
increased 15.4% compared to August 2012. NYSE Euronext’s Tape A
matched market share in September 2012 was 31.1%, down from 36.3% in
September 2011 and down from 31.6% in August 2012.
-
The preliminary average net revenue per transaction type (as defined
below) for each of the primary trading venues in the third quarter of
2012 is included below:
|
|
|
|
|
|
|
Preliminary
|
|
Trading Venue
|
|
3Q11
|
|
2Q12
|
|
3Q12
|
|
European Derivatives (ex. Bclear)1
|
|
$0.679
|
|
$0.674
|
|
$0.65
|
|
U.S. Derivatives2
|
|
$0.154
|
|
$0.148
|
|
$0.14
|
|
European Cash3
|
|
$0.635
|
|
$0.519
|
|
$0.53
|
|
U.S. Cash4
|
|
$0.038
|
|
$0.043
|
|
$0.039
|
|
1 Average net revenue per contract, excluding
Bclear.
|
|
2 Average net revenue per contract. Excludes
NYSE Liffe U.S. trading volume.
|
|
3 Average net revenue per transaction.
|
|
4 Average net revenue per 100 shares handled.
|
Derivatives Trading
European Derivatives
-
NYSE Euronext European derivatives products ADV in September 2012 of
3.5 million contracts decreased 28.2% compared to September 2011, but
increased 6.5% from August 2012 levels.
-
The 3.5 million in European derivatives futures and options contracts
ADV in September 2012 consisted of 2.9 million contracts executed
through our full-service LIFFE CONNECT trading platform and 0.6
million contracts, or 16.9%, executed through Bclear, NYSE Liffe's
trade administration and clearing service for OTC products. Excluding
Bclear, NYSE Liffe's trade administration and clearing service for OTC
products, European derivatives products ADV decreased 20.9% compared
to September 2011, but increased 30.6% compared to August 2012.
-
In the third quarter of 2012, European derivatives products ADV of 3.4
million contracts was 22.2% below prior year levels. The 3.4 million
in futures and options contracts ADV in the third quarter of 2012
consisted of 2.6 million contracts executed through LIFFE CONNECT
trading platform and 0.8 million contracts, or 24.5%, executed through
Bclear.
-
Year-to-date, European derivatives products ADV of 3.8 million
contracts was 20.4% below prior year levels. The 3.8 million in
futures and options contracts ADV year-to-date consisted of 2.7
million contracts executed through LIFFE CONNECT trading platform and
1.1 million contracts, or 28.4%, executed through Bclear.
-
Total fixed income products ADV of 2.0 million contracts in September
2012 decreased 21.5% from September 2011, but increased 39.6% from
August 2012. In the third quarter of 2012, total fixed income products
ADV of 1.7 million contracts was 26.2% below prior year levels.
Year-to-date, total fixed income products ADV of 1.8 million contracts
was 24.2% below prior year levels.
-
Total equity products (including Bclear) ADV of 1.4 million contracts
in September 2012 decreased 37.2% compared to September 2011 and
decreased 21.0% from August 2012. The 1.4 million contracts in equity
products ADV in September 2012 consisted of 0.8 million contracts in
individual equity products ADV and 0.6 million contracts in equity
index products ADV. The 0.8 million contracts in individual equity
products ADV consisted of 0.4 million in futures contracts, which
represented a 59.2% decrease compared to September 2011 and 0.4
million in options contracts, which represented a 18.8% decrease
compared to September 2011. The average net rate per contract for
individual equity futures contracts is significantly lower than other
European derivatives products. In the third quarter of 2012, total
equity products ADV of 1.6 million contracts were 19.4% below prior
year levels. Year-to-date, total equity products ADV of 1.9 million
contracts was 17.4% below prior year levels.
-
Total commodities products ADV of approximately 94,000 contracts in
September 2012 increased 2.8% compared to September 2011 and increased
5.7% compared to August 2012. In the third quarter of 2012, total
commodities product ADV of 100,000 contracts was 27.7% above prior
year levels. Year-to-date, total commodities product ADV of
87,000 contracts was 3.9% above prior year levels.
U.S. Derivatives
-
NYSE Euronext U.S. equity options ADV of 4.1 million contracts in
September 2012 decreased 10.2% compared to September 2011, but
increased 33.5% compared to August 2012. In the third quarter of 2012,
U.S. equity options ADV of 3.5 million contracts was 27.4% below prior
year levels. Year-to-date, U.S. equity options ADV of 3.9 million
contracts was 13.2% below prior year levels.
-
Total U.S. consolidated equity options ADV decreased 7.4% to 15.9
million contracts in September 2012 compared to September 2011, but
increased 27.5% compared to August 2012. In the third quarter of 2012,
U.S. consolidated equity options ADV of 13.8 million contracts was
25.2% below prior year levels. Year-to-date, U.S. consolidated equity
options ADV of 14.9 million contracts was 13.5% below prior year
levels.
-
NYSE Euronext’s U.S. options exchanges accounted for 26.0% of total
U.S. consolidated equity options trading in September 2012, down from
26.8% in September 2011, but up from 24.8% in August 2012.
-
NYSE Liffe U.S. ADV of approximately 83,700 contracts decreased 26.2%
compared to September 2011, but increased 32.4% from August 2012. In
the third quarter of 2012, U.S. futures and futures options ADV of
66,400 contracts was 43.7% below prior year levels. Year-to-date, U.S.
futures and futures options ADV of 78,600 contracts was 1.0% above
prior year levels.
Cash Trading
European Cash
-
NYSE Euronext European cash products ADV of 1.4 million transactions
in September 2012 decreased 24.2% compared to September 2011 and
increased 31.3% compared to August 2012.
-
September 2012 market share in European Cash products was 68.7%, up
from 65.7% in September 2011 and up from 68.2% in August 2012.
-
In the third quarter of 2012, European cash products ADV of 1.3
million transactions was 30.9% below prior year levels.
-
Year-to-date, European cash products ADV of 1.5 million transactions
was 12.5% below prior year levels.
U.S. Cash
-
NYSE Euronext U.S. cash products handled ADV in September 2012
decreased 34.7% to 1.7 billion shares compared to September 2011, but
increased 15.4% from August 2012.
-
In the third quarter of 2012, U.S. cash products handled ADV was 1.6
billion shares, down 39.3% from prior year levels.
-
Year-to-date, U.S. cash products handled ADV was 1.7 billion shares,
down 25.8% from prior year levels.
-
NYSE Euronext’s Tape A matched market share in September 2012 was
31.1%, down from 36.3% in September 2011 and down from 31.6% in August
2012.
Exchange Traded Funds
-
NYSE Euronext U.S. matched exchange-traded funds ADV (included in
volumes for Tape B and Tape C) of 200 million shares in September 2012
decreased 52.5% compared to September 2011, but increased 19.2%
compared to August 2012.
-
In the third quarter of 2012, NYSE Euronext U.S. matched
exchange-traded funds ADV of 186 million shares was 54.6% below prior
year levels.
-
Year-to-date, NYSE Euronext U.S. matched exchange-traded funds ADV of
215 million shares was 33.6% below prior year levels.
Other Metrics
-
Beginning with the third quarter of 2012, the Financial Industry
Regulatory Authority (“FINRA”) will no longer utilize office space and
other services provided by NYSE Euronext. As a result, “other revenue”
will be lower by approximately $3 million beginning with the third
quarter of 2012.
-
The average EUR/USD exchange rate for the third quarter of 2012 of
$1.25 represented a decrease of 2.5% from the second quarter of 2012
and a decrease of 11.5% compared to the third quarter of 2011. The
average GBP/USD exchange rate for the third quarter of 2012 of $1.58
represented a decrease of 0.1% from the second quarter of 2012 and a
decrease of 1.9% compared to the third quarter of 2011.
-
During the third quarter of 2012, a total of 4.7 million shares were
repurchased at an average price of $25.46. The current stock
repurchase authorization has $128 million remaining as of September
30, 2012. As a result of these repurchases, the weighted average
diluted shares outstanding in the third quarter of 2012 was 247
million shares.
Please click
here for the Monthly Transaction Activity Data Table.
About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial markets
and provider of innovative trading technologies. The company's exchanges
in Europe and the United States trade equities, futures, options,
fixed-income and exchange-traded products. With approximately 8,000
listed issues (excluding European Structured Products), NYSE Euronext's
equities markets - the New York Stock Exchange, NYSE Euronext, NYSE MKT,
NYSE Alternext and NYSE Arca - represent one-third of the world’s
equities trading, the most liquidity of any global exchange group. NYSE
Euronext also operates NYSE Liffe, one of the leading European
derivatives businesses and the world's second-largest derivatives
business by value of trading. The company offers comprehensive
commercial technology, connectivity and market data products and
services through NYSE Technologies. NYSE Euronext is in the S&P 500
index. For more information, please visit: http://www.nyx.com.
Disclaimer and Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements, including
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. Such forward-looking statements include,
but are not limited to, statements concerning NYSE Euronext's plans,
objectives, expectations and intentions and other statements that are
not historical or current facts. Forward-looking statements are based on
NYSE Euronext's current expectations and involve risks and uncertainties
that could cause actual results to differ materially from those
expressed or implied in such forward-looking statements. Factors that
could cause NYSE Euronext's results to differ materially from current
expectations include, but are not limited to: NYSE Euronext's ability to
implement its strategic initiatives, economic, political and market
conditions and fluctuations, government and industry regulation,
interest rate risk and U.S. and global competition, and other factors
detailed in NYSE Euronext's 2011 Annual Report on Form 10-K and other
periodic reports filed with the U.S. Securities and Exchange Commission
or the French Autorité des Marchés Financiers. In addition, these
statements are based on a number of assumptions that are subject to
change. Accordingly, actual results may be materially higher or lower
than those projected. The inclusion of such projections herein should
not be regarded as a representation by NYSE Euronext that the
projections will prove to be correct. This press release speaks only as
of this date. NYSE Euronext disclaims any duty to update the information
herein.
1 All NYSE Euronext derivatives transactions count buy and
sell orders together as a single transaction. NYSE Euronext European
equities transactions count each buy and sell order as separate
transactions, NYSE Euronext U.S. equities transactions count buy and
sell orders together as a single transaction.
|
NYSE Euronext
|
|
Monthly Volume Summary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average Daily Volume
|
|
Total Volume
|
|
Average Daily Volume
|
|
Total Volume
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% Chg vs.
|
|
|
|
% Chg vs.
|
|
(Unaudited; contracts in thousands)
|
|
Sep-12
|
|
Sep-11
|
|
% Chg
|
|
Sep-12
|
|
Sep-11
|
|
% Chg
|
|
YTD 2012
|
|
YTD 2011
|
|
YTD 2012
|
|
YTD 2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Trading Days - European Cash
|
|
20
|
|
22
|
|
|
|
20
|
|
22
|
|
|
|
192
|
|
|
|
192
|
|
|
|
Number of Trading Days - European Derivatives
|
|
20
|
|
22
|
|
|
|
20
|
|
22
|
|
|
|
193
|
|
|
|
193
|
|
|
|
Number of Trading Days - U.S. Markets
|
|
19
|
|
21
|
|
|
|
19
|
|
21
|
|
|
|
188
|
|
|
|
188
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
European Derivatives Products
|
|
3,455
|
|
4,809
|
|
-28.2%
|
|
69,105
|
|
105,799
|
|
-34.7%
|
|
3,781
|
|
-20.4%
|
|
729,643
|
|
-20.4%
|
|
of which Bclear
|
|
584
|
|
1,179
|
|
-50.4%
|
|
11,685
|
|
25,941
|
|
-55.0%
|
|
1,075
|
|
-12.7%
|
|
207,412
|
|
-12.7%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Fixed Income Products
|
|
1,998
|
|
2,547
|
|
-21.5%
|
|
39,965
|
|
56,029
|
|
-28.7%
|
|
1,818
|
|
-24.2%
|
|
350,918
|
|
-24.2%
|
|
Short Term Interest Rate Products
|
|
1,841
|
|
2,400
|
|
-23.3%
|
|
36,828
|
|
52,801
|
|
-30.3%
|
|
1,668
|
|
-26.2%
|
|
321,829
|
|
-26.2%
|
|
Medium and Long Term Interest Rate Products 1
|
|
157
|
|
147
|
|
6.9%
|
|
3,138
|
|
3,228
|
|
-2.8%
|
|
151
|
|
7.2%
|
|
29,089
|
|
7.2%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Equity Products 2
|
|
1,363
|
|
2,171
|
|
-37.2%
|
|
27,261
|
|
47,760
|
|
-42.9%
|
|
1,875
|
|
-17.4%
|
|
361,965
|
|
-17.4%
|
|
Individual Equity Products
|
|
814
|
|
1,483
|
|
-45.1%
|
|
16,288
|
|
32,636
|
|
-50.1%
|
|
1,388
|
|
-17.1%
|
|
267,841
|
|
-17.1%
|
|
Futures
|
|
395
|
|
967
|
|
-59.2%
|
|
7,895
|
|
21,266
|
|
-62.9%
|
|
930
|
|
-12.6%
|
|
179,402
|
|
-12.6%
|
|
Options
|
|
420
|
|
517
|
|
-18.8%
|
|
8,393
|
|
11,369
|
|
-26.2%
|
|
458
|
|
-25.1%
|
|
88,439
|
|
-25.1%
|
|
Equity Index Products
|
|
549
|
|
687
|
|
-20.2%
|
|
10,972
|
|
15,124
|
|
-27.5%
|
|
488
|
|
-18.0%
|
|
94,124
|
|
-18.0%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
of which Bclear
|
|
584
|
|
1,179
|
|
-50.4%
|
|
11,685
|
|
25,941
|
|
-55.0%
|
|
1,075
|
|
-12.7%
|
|
207,412
|
|
-12.7%
|
|
Individual Equity Products
|
|
456
|
|
1,065
|
|
-57.2%
|
|
9,118
|
|
23,431
|
|
-61.1%
|
|
1,000
|
|
-13.0%
|
|
193,037
|
|
-13.0%
|
|
Futures
|
|
382
|
|
962
|
|
-60.2%
|
|
7,650
|
|
21,154
|
|
-63.8%
|
|
904
|
|
-13.5%
|
|
174,532
|
|
-13.5%
|
|
Options
|
|
73
|
|
104
|
|
-29.1%
|
|
1,469
|
|
2,277
|
|
-35.5%
|
|
96
|
|
-8.0%
|
|
18,505
|
|
-8.0%
|
|
Equity Index Products
|
|
128
|
|
114
|
|
12.5%
|
|
2,567
|
|
2,509
|
|
2.3%
|
|
74
|
|
-9.3%
|
|
14,375
|
|
-9.3%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commodity Products
|
|
94
|
|
91
|
|
2.8%
|
|
1,879
|
|
2,010
|
|
-6.5%
|
|
87
|
|
3.9%
|
|
16,761
|
|
3.9%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Derivatives Products
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Options 3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NYSE Euronext Options Contracts
|
|
4,122
|
|
4,588
|
|
-10.2%
|
|
78,318
|
|
96,351
|
|
-18.7%
|
|
3,857
|
|
-13.2%
|
|
725,134
|
|
-13.7%
|
|
Total Consolidated Options Contracts
|
|
15,863
|
|
17,134
|
|
-7.4%
|
|
301,402
|
|
359,818
|
|
-16.2%
|
|
14,862
|
|
-13.5%
|
|
2,794,081
|
|
-14.0%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NYSE Group Share of Total
|
|
26.0%
|
|
26.8%
|
|
|
|
26.0%
|
|
26.8%
|
|
|
|
26.0%
|
|
0.1%
|
|
26.0%
|
|
0.1%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NYSE Liffe U.S.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Futures and Futures Options Volume*
|
|
83.7
|
|
113.4
|
|
-26.2%
|
|
1,673
|
|
2,494
|
|
-32.9%
|
|
78.6
|
|
1.0%
|
|
15,178.2
|
|
0.5%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
European Cash Products (trades in thousands)
|
|
1,426
|
|
1,882
|
|
-24.2%
|
|
28,530
|
|
41,402
|
|
-31.1%
|
|
1,534
|
|
-12.5%
|
|
294,556
|
|
-12.9%
|
|
Equities
|
|
1,377
|
|
1,804
|
|
-23.7%
|
|
27,533
|
|
39,684
|
|
-30.6%
|
|
1,483
|
|
-11.9%
|
|
284,805
|
|
-12.4%
|
|
Exchange-Traded Funds
|
|
14
|
|
26
|
|
-47.7%
|
|
274
|
|
576
|
|
-52.4%
|
|
14
|
|
-33.2%
|
|
2,650
|
|
-33.6%
|
|
Structured Products
|
|
30
|
|
47
|
|
-35.6%
|
|
607
|
|
1,037
|
|
-41.5%
|
|
32
|
|
-25.1%
|
|
6,125
|
|
-25.5%
|
|
Bonds
|
|
6
|
|
5
|
|
20.5%
|
|
116
|
|
106
|
|
9.5%
|
|
5
|
|
0.9%
|
|
976
|
|
0.4%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Cash Products (shares in millions) 5
|
|
1,669
|
|
2,558
|
|
-34.7%
|
|
31,720
|
|
53,709
|
|
-40.9%
|
|
1,730
|
|
-25.8%
|
|
325,180
|
|
-26.2%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NYSE Listed (Tape A) Issues 4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
1,218
|
|
1,761
|
|
-30.8%
|
|
23,146
|
|
36,976
|
|
-37.4%
|
|
1,237
|
|
-24.8%
|
|
232,644
|
|
-25.2%
|
|
Matched Volume 6
|
|
1,160
|
|
1,678
|
|
-30.9%
|
|
22,034
|
|
35,241
|
|
-37.5%
|
|
1,173
|
|
-24.8%
|
|
220,535
|
|
-25.2%
|
|
Total NYSE Listed Consolidated Volume
|
|
3,730
|
|
4,622
|
|
-19.3%
|
|
70,866
|
|
97,054
|
|
-27.0%
|
|
3,742
|
|
-15.6%
|
|
703,537
|
|
-16.1%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share of Total Consolidated Volume
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
32.7%
|
|
38.1%
|
|
-5.4%
|
|
32.7%
|
|
38.1%
|
|
-5.4%
|
|
33.1%
|
|
-4.0%
|
|
33.1%
|
|
-4.0%
|
|
Matched Volume 6
|
|
31.1%
|
|
36.3%
|
|
-5.2%
|
|
31.1%
|
|
36.3%
|
|
-5.2%
|
|
31.3%
|
|
-3.8%
|
|
31.3%
|
|
-3.8%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NYSE Arca, MKT and Regional (Tape B) Listed Issues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
241
|
|
477
|
|
-49.5%
|
|
4,583
|
|
10,025
|
|
-54.3%
|
|
255
|
|
-33.5%
|
|
48,029
|
|
-33.8%
|
|
Matched Volume 6
|
|
219
|
|
432
|
|
-49.3%
|
|
4,161
|
|
9,074
|
|
-54.1%
|
|
230
|
|
-33.5%
|
|
43,238
|
|
-33.8%
|
|
Total NYSE Arca & MKT Listed Consolidated Volume
|
|
1,048
|
|
1,806
|
|
-41.9%
|
|
19,919
|
|
37,916
|
|
-47.5%
|
|
1,083
|
|
-26.9%
|
|
203,650
|
|
-27.3%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share of Total Consolidated Volume
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
23.0%
|
|
26.4%
|
|
-3.4%
|
|
23.0%
|
|
26.4%
|
|
-3.4%
|
|
23.6%
|
|
-2.3%
|
|
23.6%
|
|
-2.3%
|
|
Matched Volume 6
|
|
20.9%
|
|
23.9%
|
|
-3.0%
|
|
20.9%
|
|
23.9%
|
|
-3.0%
|
|
21.2%
|
|
-2.1%
|
|
21.2%
|
|
-2.1%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nasdaq Listed (Tape C) Issues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
210
|
|
319
|
|
-34.2%
|
|
3,991
|
|
6,708
|
|
-40.5%
|
|
237
|
|
-21.8%
|
|
44,507
|
|
-22.2%
|
|
Matched Volume 6
|
|
181
|
|
282
|
|
-35.8%
|
|
3,443
|
|
5,928
|
|
-41.9%
|
|
202
|
|
-22.2%
|
|
38,067
|
|
-22.6%
|
|
Total Nasdaq Listed Consolidated Volume
|
|
1,796
|
|
2,089
|
|
-14.1%
|
|
34,117
|
|
43,874
|
|
-22.2%
|
|
1,753
|
|
-15.6%
|
|
329,548
|
|
-16.1%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share of Total Consolidated Volume
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
11.7%
|
|
15.3%
|
|
-3.6%
|
|
11.7%
|
|
15.3%
|
|
-3.6%
|
|
13.5%
|
|
-1.1%
|
|
13.5%
|
|
-1.1%
|
|
Matched Volume 6
|
|
10.1%
|
|
13.5%
|
|
-3.4%
|
|
10.1%
|
|
13.5%
|
|
-3.4%
|
|
11.6%
|
|
-0.9%
|
|
11.6%
|
|
-0.9%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange-Traded Funds 5,7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
220
|
|
465
|
|
-52.7%
|
|
4,181
|
|
9,769
|
|
-57.2%
|
|
239
|
|
-33.6%
|
|
45,002
|
|
-33.9%
|
|
Matched Volume 6
|
|
200
|
|
421
|
|
-52.5%
|
|
3,796
|
|
8,832
|
|
-57.0%
|
|
215
|
|
-33.6%
|
|
40,453
|
|
-34.0%
|
|
Total ETF Consolidated Volume
|
|
987
|
|
1,797
|
|
-45.1%
|
|
18,758
|
|
37,737
|
|
-50.3%
|
|
1,046
|
|
-26.1%
|
|
196,741
|
|
-26.5%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share of Total Consolidated Volume
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handled Volume 5
|
|
22.3%
|
|
25.9%
|
|
-3.6%
|
|
22.3%
|
|
25.9%
|
|
-3.6%
|
|
22.9%
|
|
-2.6%
|
|
22.9%
|
|
-2.6%
|
|
Matched Volume 6
|
|
20.2%
|
|
23.4%
|
|
-3.2%
|
|
20.2%
|
|
23.4%
|
|
-3.2%
|
|
20.6%
|
|
-2.3%
|
|
20.6%
|
|
-2.3%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Data includes currency products.
|
|
2 Includes all trading activities for Bclear, NYSE
Liffe's clearing service for wholesale derivatives.
|
|
3 Includes trading in U.S. equity options contracts, not
equity-index options.
|
|
4 Includes all volume executed in NYSE Group crossing
sessions.
|
|
5 Represents the total number of shares of equity
securities and ETFs internally matched on the NYSE Group's exchanges
or routed to and executed at an external market center. NYSE Arca
routing includes odd-lots.
|
|
6 Represents the total number of shares of equity
securities and ETFs executed on the NYSE Group's exchanges.
|
|
7 Data included in previously identified categories.
|
|
* ADVs calculated with the appropriate number of NYSE
Liffe U.S. trading days.
|
|
Source: NYSE Euronext, Options Clearing Corporation and Consolidated
Tape as reported for equity securities.
|
|
All trading activity is single-counted, except European cash trading
which is double counted to include both buys and sells.
|
Please follow us at:
Exchanges
Blog
Facebook
LinkedIn
Twitter
Source: NYSE Euronext
NYSE Euronext
Media:
Amsterdam, +31-20-550-4488
Brussels,
+32-2-509-1392
Lisbon, +351-217-900-029
London,
+44-20-7379-2789
New York, +1-212-656-2411
Paris,
+33-1-49-27-11-33
or
Investor Relations:
New York,
+1-212-656-5700